reference/1090592

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/1090592

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase II\|Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	1208
issn	1432-0843 0344-5704
issueIdentifier	5
pageRange	1203-1208
publicationName	Cancer Chemotherapy and Pharmacology
startingPage	1203
bibliographicCitation	Chouaid C, Nathan F, Pemberton K, Morris T. A phase II, randomized, multicenter study to assess the efficacy, safety, and tolerability of zibotentan (ZD4054) in combination with pemetrexed in patients with advanced non-small cell lung cancer. Cancer Chemother Pharmacol. 2011 May;67(5):1203–8. doi: 10.1007/s00280-010-1538-z. PMID: 21153822.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_23cb220736b5205b05b4def60a1a92cd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c00495e216013a6819604fd665264284 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c6c8ed79ee173ad09d191177ed922414 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_14b49ae156805efb0391a7a775a61803
date	2010-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1007/s00280-010-1538-z https://pubmed.ncbi.nlm.nih.gov/21153822
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2664 https://portal.issn.org/resource/ISSN/0344-5704 https://portal.issn.org/resource/ISSN/1432-0843
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/ https://scigraph.springernature.com/
title	A phase II, randomized, multicenter study to assess the efficacy, safety, and tolerability of zibotentan (ZD4054) in combination with pemetrexed in patients with advanced non-small cell lung cancer
discusses	http://id.nlm.nih.gov/mesh/M0009679 http://id.nlm.nih.gov/mesh/M0499457 http://id.nlm.nih.gov/mesh/M0009376 http://id.nlm.nih.gov/mesh/M0018277 http://id.nlm.nih.gov/mesh/M0227083
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D002289Q000188 http://id.nlm.nih.gov/mesh/D000971Q000627 http://id.nlm.nih.gov/mesh/D008175Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D011759Q000008 http://id.nlm.nih.gov/mesh/D002289Q000473 http://id.nlm.nih.gov/mesh/D000068437 http://id.nlm.nih.gov/mesh/D002289Q000401 http://id.nlm.nih.gov/mesh/D004311 http://id.nlm.nih.gov/mesh/D000971Q000009 http://id.nlm.nih.gov/mesh/D009362 http://id.nlm.nih.gov/mesh/D005971Q000008 http://id.nlm.nih.gov/mesh/D006147Q000031 http://id.nlm.nih.gov/mesh/D008175Q000473 http://id.nlm.nih.gov/mesh/D006147Q000008 http://id.nlm.nih.gov/mesh/D008175Q000401 http://id.nlm.nih.gov/mesh/D015996 http://id.nlm.nih.gov/mesh/D006801
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9910224 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135410875 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7168 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23939 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6873 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_59dd577145d725309f037ed043ab8fb3

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127855448 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135945851 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129439837

Total number of triples: 56.